Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The autoimmune regulator (AIRE) is a transcription factor primarily expressed in the medullary thymic epithelial cells. Its function is to eliminate self-reactive T cells during their development, ensuring immune tolerance to the body's own tissues. Loss or mutation of AIRE leads to autoimmunity, including autoimmune polyendocrine syndrome type I. There is no established direct therapeutic targeting of AIRE, but it is a vital regulator of immune self-tolerance and its gene is a biomarker for several autoimmune syndromes
Not applicable for drugs, but biological mechanism involves expression of tissue-restricted antigens in thymic epithelial cells driving central immune tolerance through negative thymic selection
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autoimmune regulator (AIRE).